首页 > 最新文献

Federal practitioner : for the health care professionals of the VA, DoD, and PHS最新文献

英文 中文
Implementation of a Virtual Huddle to Support Patient Care During the COVID-19 Pandemic. 实施虚拟分组以支持COVID-19大流行期间的患者护理。
Pub Date : 2022-08-01 Epub Date: 2022-08-15 DOI: 10.12788/fp.0310
Uma Ayyala, Shazia Raheem, Jefferson L Triozzi, Andrew Hunter, Elwyn Welch, Stephen Bujarski, Christina Kao, Lavannya Pandit, Kanta Velamuri, Venkata D Bandi

Background: During a surge of COVID-19 cases, the volume of acute care patients with hypoxemic respiratory failure placed a high burden of responsibility on internal medicine, pulmonary and critical care medicine, and clinical pharmacy services.

Observations: We describe the COVID-19 Tele-Huddle Program, a novel approach to communication between key stakeholders in COVID-19 patient care through a daily video conferencing huddle. The program was implemented during a 4-week surge in COVID-19 cases at a large, academic medical center in Houston, Texas. Data collected during the COVID-19 Tele-Huddle Program included the type and number of interventions implemented, number of patients discussed, and COVID-19 therapies provided. In addition, hospital medicine team members completed a user-experience survey.

Conclusions: A multidisciplinary consultation service using video conferencing can support the care of patients with high disease severity without overwhelming existing inpatient medical, intensive care, and pharmacy services.

背景:在COVID-19病例激增期间,急性护理低氧性呼吸衰竭患者的数量给内科、肺部和重症监护医学以及临床药学服务带来了沉重的责任负担。观察结果:我们描述了COVID-19远程会议计划,这是一种通过每日视频会议在COVID-19患者护理的关键利益相关者之间进行沟通的新方法。该计划是在德克萨斯州休斯顿一家大型学术医疗中心的COVID-19病例激增4周期间实施的。在COVID-19远程会诊项目期间收集的数据包括实施的干预措施的类型和数量、讨论的患者人数以及提供的COVID-19治疗方法。此外,医院医学团队成员完成了一项用户体验调查。结论:采用视频会议的多学科会诊服务可以支持高疾病严重程度患者的护理,而不会压倒现有的住院医疗、重症监护和药房服务。
{"title":"Implementation of a Virtual Huddle to Support Patient Care During the COVID-19 Pandemic.","authors":"Uma Ayyala,&nbsp;Shazia Raheem,&nbsp;Jefferson L Triozzi,&nbsp;Andrew Hunter,&nbsp;Elwyn Welch,&nbsp;Stephen Bujarski,&nbsp;Christina Kao,&nbsp;Lavannya Pandit,&nbsp;Kanta Velamuri,&nbsp;Venkata D Bandi","doi":"10.12788/fp.0310","DOIUrl":"https://doi.org/10.12788/fp.0310","url":null,"abstract":"<p><strong>Background: </strong>During a surge of COVID-19 cases, the volume of acute care patients with hypoxemic respiratory failure placed a high burden of responsibility on internal medicine, pulmonary and critical care medicine, and clinical pharmacy services.</p><p><strong>Observations: </strong>We describe the COVID-19 Tele-Huddle Program, a novel approach to communication between key stakeholders in COVID-19 patient care through a daily video conferencing huddle. The program was implemented during a 4-week surge in COVID-19 cases at a large, academic medical center in Houston, Texas. Data collected during the COVID-19 Tele-Huddle Program included the type and number of interventions implemented, number of patients discussed, and COVID-19 therapies provided. In addition, hospital medicine team members completed a user-experience survey.</p><p><strong>Conclusions: </strong>A multidisciplinary consultation service using video conferencing can support the care of patients with high disease severity without overwhelming existing inpatient medical, intensive care, and pharmacy services.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"e0310"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652024/pdf/fp-39-08-e0310.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40486168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Stewardship Improvement Initiative at a Veterans Health Administration Ambulatory Care Center. 抗生素管理改进倡议在退伍军人健康管理局门诊护理中心。
Pub Date : 2022-08-01 Epub Date: 2022-08-09 DOI: 10.12788/fp.0302
David Cooperman, Winnie Angerer, James Barry Fagan

Background: The negative impact of unnecessary antibiotic prescribing is well known and includes risks of antibiotic adverse effects, overgrowth of pathogenic organisms, unnecessary costs, and selection of antibiotic-resistant organisms in the populace at large. Acute viral respiratory infections are among the leading causes of inappropriate antibiotic usage.

Methods: This study examined the effect on inappropriate antibiotic prescribing rates of educating clinicians regarding antibiotic stewardship and making a prepackaged kit (containing symptom relief and patient education) for clinicians to distribute to patients with viral upper respiratory tract infections vs writing a prescription for antibiotics.

Results: Between December 1, 2018, and March 31, 2019, 357 viral illness support packs were distributed. Antibiotic prescriptions for the diagnostic codes pertaining to viral upper respiratory tract infections were tracked and compared to a similar period from December 1, 2017, to March 31, 2018. A 9% reduction in antibiotic prescriptions was observed (P = .02).

Conclusions: The results of this project demonstrate that the combination of patient education and the ready availability of a nonantibiotic symptomatic treatment option can significantly decrease the unnecessary prescribing of antibiotics for viral illnesses.

背景:不必要的抗生素处方的负面影响是众所周知的,包括抗生素不良反应的风险,致病生物的过度生长,不必要的成本,以及在广大民众中选择抗生素耐药生物。急性病毒性呼吸道感染是不适当使用抗生素的主要原因之一。方法:本研究考察了对临床医生进行抗生素管理教育并制作预包装工具包(包含症状缓解和患者教育)供临床医生分发给病毒性上呼吸道感染患者与开具抗生素处方的影响。结果:2018年12月1日至2019年3月31日,共发放病毒性疾病支持包357份。追踪了与病毒性上呼吸道感染有关的诊断代码的抗生素处方,并将其与2017年12月1日至2018年3月31日的类似时期进行了比较。抗生素处方减少9% (P = 0.02)。结论:该项目的结果表明,患者教育和非抗生素对症治疗方案的现成可用性相结合,可以显着减少不必要的病毒性疾病抗生素处方。
{"title":"Antibiotic Stewardship Improvement Initiative at a Veterans Health Administration Ambulatory Care Center.","authors":"David Cooperman,&nbsp;Winnie Angerer,&nbsp;James Barry Fagan","doi":"10.12788/fp.0302","DOIUrl":"https://doi.org/10.12788/fp.0302","url":null,"abstract":"<p><strong>Background: </strong>The negative impact of unnecessary antibiotic prescribing is well known and includes risks of antibiotic adverse effects, overgrowth of pathogenic organisms, unnecessary costs, and selection of antibiotic-resistant organisms in the populace at large. Acute viral respiratory infections are among the leading causes of inappropriate antibiotic usage.</p><p><strong>Methods: </strong>This study examined the effect on inappropriate antibiotic prescribing rates of educating clinicians regarding antibiotic stewardship and making a prepackaged kit (containing symptom relief and patient education) for clinicians to distribute to patients with viral upper respiratory tract infections vs writing a prescription for antibiotics.</p><p><strong>Results: </strong>Between December 1, 2018, and March 31, 2019, 357 viral illness support packs were distributed. Antibiotic prescriptions for the diagnostic codes pertaining to viral upper respiratory tract infections were tracked and compared to a similar period from December 1, 2017, to March 31, 2018. A 9% reduction in antibiotic prescriptions was observed <i>(P</i> = .02).</p><p><strong>Conclusions: </strong>The results of this project demonstrate that the combination of patient education and the ready availability of a nonantibiotic symptomatic treatment option can significantly decrease the unnecessary prescribing of antibiotics for viral illnesses.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"346-348a"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652026/pdf/fp-39-08-346.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40486170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nodular Sclerosing Hodgkin Lymphoma With Paraneoplastic Cerebellar Degeneration. 结节硬化霍奇金淋巴瘤伴副肿瘤小脑变性。
Pub Date : 2022-08-01 Epub Date: 2022-07-14 DOI: 10.12788/fp.0293
Lcdr Denise Teh, Lt Hunter Culp, Aaron Venable

Background: There are a variety of paraneoplastic syndromes associated with Hodgkin lymphoma including paraneoplastic cerebellar degeneration (PCD), which is associated with unique autoantibodies, such as anti-Tr antibody. Most of these autoimmune phenomena involve older adult patients with abrupt, acute presentations.

Case presentation: We report an atypical case of a young adult female patient with slow progressive onset of PCD symptoms with subsequent detection and treatment of Hodgkin lymphoma.

Conclusions: Early detection of PCD is critical, as treatment of the underlying malignancy decreases overall morbidity and disability.

背景:有多种与霍奇金淋巴瘤相关的副肿瘤综合征,包括副肿瘤小脑变性(PCD),它与独特的自身抗体相关,如抗tr抗体。这些自身免疫现象大多发生在老年患者身上,表现突发性、急性。病例介绍:我们报告一个非典型病例的年轻成年女性患者缓慢进行性发作的PCD症状与随后的霍奇金淋巴瘤的检测和治疗。结论:早期发现PCD是至关重要的,因为治疗潜在的恶性肿瘤可以降低总体发病率和致残率。
{"title":"Nodular Sclerosing Hodgkin Lymphoma With Paraneoplastic Cerebellar Degeneration.","authors":"Lcdr Denise Teh,&nbsp;Lt Hunter Culp,&nbsp;Aaron Venable","doi":"10.12788/fp.0293","DOIUrl":"https://doi.org/10.12788/fp.0293","url":null,"abstract":"<p><strong>Background: </strong>There are a variety of paraneoplastic syndromes associated with Hodgkin lymphoma including paraneoplastic cerebellar degeneration (PCD), which is associated with unique autoantibodies, such as anti-Tr antibody. Most of these autoimmune phenomena involve older adult patients with abrupt, acute presentations.</p><p><strong>Case presentation: </strong>We report an atypical case of a young adult female patient with slow progressive onset of PCD symptoms with subsequent detection and treatment of Hodgkin lymphoma.</p><p><strong>Conclusions: </strong>Early detection of PCD is critical, as treatment of the underlying malignancy decreases overall morbidity and disability.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"S18-S19"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662306/pdf/fp-39-08s-s18.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postprandial Right Upper Quadrant Abdominal Pain. 餐后右上腹部疼痛。
Pub Date : 2022-08-01 Epub Date: 2022-08-18 DOI: 10.12788/fp.0301
Megan A Hemmrich, Sankalp Goberdhan, Igor Sirotkin
A 53-year-old male patient presented to the emergency department following a primary care office visit with sudden onset right upper quadrant abdominal pain that persisted for 3 weeks, worsening over the last 2 days. The abdominal pain worsened after eating or drinking and mildly improved with omeprazole. Associated symptoms included intermittent fever, night sweats, fatigue, and bloating since onset without vomiting or diarrhea. He reported a “complicated” cholecystectomy at an outside facility 6 months prior and that his “gallbladder was adhered to his duodenum,” though outside records were not available. Additional medical history included diverticulosis with prior flares of diverticulitis but no recent flares or treatments. His home medications included acetaminophen, naproxen, intranasal fluticasone, omeprazole, gabapentin, baclofen, trazodone, and antihistamines. He reported no tobacco or illicit drug use and stated he consumed a 6 pack of beer every 6 weeks. Initial vital signs in the emergency department demonstrated an afebrile oral temperature with unremarkable blood pressure and pulse. He was alert and oriented and did not appear in significant acute distress. Physical examination of the abdomen demonstrated a nondistended abdomen, normal active bowel sounds in all 4 quadrants, and mild right upper and lower quadrant tenderness to soft and deep palpation with release. Significant laboratory values included elevated C-reactive protein of 44.1 mg/L and mild leukocytosis of 11.1 K/μL (reference range, 4.00-10.60 K/μL). The basic metabolic panel, liver-associated enzymes, and lipase levels were within normal limits. The initial imaging study was a computed tomography (CT) of the abdomen and pelvis with oral and IV contrast. The radiology report depicted a thin, needle-like hypodense foreign body approximately 8 cm in length in the proximal duodenum, s l i g h t l y p r o truding extraluminally, and at least a moderate amount of surrounding inflammation without abscess or free air (Figure 1).
{"title":"Postprandial Right Upper Quadrant Abdominal Pain.","authors":"Megan A Hemmrich,&nbsp;Sankalp Goberdhan,&nbsp;Igor Sirotkin","doi":"10.12788/fp.0301","DOIUrl":"https://doi.org/10.12788/fp.0301","url":null,"abstract":"A 53-year-old male patient presented to the emergency department following a primary care office visit with sudden onset right upper quadrant abdominal pain that persisted for 3 weeks, worsening over the last 2 days. The abdominal pain worsened after eating or drinking and mildly improved with omeprazole. Associated symptoms included intermittent fever, night sweats, fatigue, and bloating since onset without vomiting or diarrhea. He reported a “complicated” cholecystectomy at an outside facility 6 months prior and that his “gallbladder was adhered to his duodenum,” though outside records were not available. Additional medical history included diverticulosis with prior flares of diverticulitis but no recent flares or treatments. His home medications included acetaminophen, naproxen, intranasal fluticasone, omeprazole, gabapentin, baclofen, trazodone, and antihistamines. He reported no tobacco or illicit drug use and stated he consumed a 6 pack of beer every 6 weeks. Initial vital signs in the emergency department demonstrated an afebrile oral temperature with unremarkable blood pressure and pulse. He was alert and oriented and did not appear in significant acute distress. Physical examination of the abdomen demonstrated a nondistended abdomen, normal active bowel sounds in all 4 quadrants, and mild right upper and lower quadrant tenderness to soft and deep palpation with release. Significant laboratory values included elevated C-reactive protein of 44.1 mg/L and mild leukocytosis of 11.1 K/μL (reference range, 4.00-10.60 K/μL). The basic metabolic panel, liver-associated enzymes, and lipase levels were within normal limits. The initial imaging study was a computed tomography (CT) of the abdomen and pelvis with oral and IV contrast. The radiology report depicted a thin, needle-like hypodense foreign body approximately 8 cm in length in the proximal duodenum, s l i g h t l y p r o truding extraluminally, and at least a moderate amount of surrounding inflammation without abscess or free air (Figure 1).","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"e0301"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652028/pdf/fp-39-08-e0301.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus Statement Supporting the Presence of Onsite Radiation Oncology Departments at VHA Medical Centers. 支持VHA医疗中心现场放射肿瘤科存在的共识声明。
Pub Date : 2022-08-01 Epub Date: 2022-08-16 DOI: 10.12788/fp.0308
Ruchika Gutt, Ronald H Shapiro, Steve P Lee, Katherine Faricy-Anderson, Lori Hoffman-Hogg, Abhishek A Solanki, Edwinette Moses, George A Dawson, Maria D Kelly

Background: Although multiple studies demonstrate that radiotherapy is underused worldwide, the impact that onsite radiation oncology at medical centers has on the use of radiotherapy is poorly studied. The Veterans Health Administration (VHA) Palliative Radiotherapy Taskforce has evaluated the impact of onsite radiation therapy on the use of palliative radiation and has made recommendations based on these findings.

Observations: Radiation consults and treatment occur in a more timely manner at VHA centers with onsite radiation therapy compared with VHA centers without onsite radiation oncology. Referring practitioners with onsite radiation oncology less frequently report difficulty contacting a radiation oncologist (0% vs 20%, respectively; P = .006) and patient travel (28% vs 71%, respectively; P < .001) as barriers to referral for palliative radiotherapy. Facilities with onsite radiation oncology are more likely to have multidisciplinary tumor boards (31% vs 3%, respectively; P = .11) and are more likely to be influenced by radiation oncology recommendations at tumor boards (69% vs 44%, respectively; P = .02).

Conclusions: The VHA Palliative Radiotherapy Taskforce recommends the optimization of the use of radiotherapy within the VHA. Radiation oncology services should be maintained where present in the VHA, with consideration for expansion of services to additional facilities. Telehealth should be used to expedite consults and treatment. Hypofractionation should be used, when appropriate, to ease travel burden. Options for transportation services and onsite housing or hospitalization should be understood by treating physicians and offered to patients to mitigate barriers related to travel.

背景:尽管多项研究表明,放疗在世界范围内未得到充分利用,但医疗中心现场放射肿瘤学对放疗使用的影响研究甚少。退伍军人健康管理局(VHA)姑息性放疗工作组评估了现场放射治疗对姑息性放疗使用的影响,并根据这些发现提出了建议。观察:与不进行现场放射肿瘤学治疗的VHA中心相比,现场放射治疗的VHA中心的放射咨询和治疗更及时。接受现场放射肿瘤学治疗的转诊医师较少报告难以联系放射肿瘤学家(分别为0%和20%);P = 0.006)和患者旅行(分别为28%对71%;P < 0.001)作为转诊姑息性放疗的障碍。拥有现场放射肿瘤学的机构更有可能拥有多学科肿瘤委员会(分别为31%和3%;P = 0.11),更有可能受到肿瘤委员会放射肿瘤学建议的影响(分别为69%对44%;P = .02)。结论:VHA姑息性放疗工作组建议在VHA内优化放疗的使用。放射肿瘤学服务应保留在VHA现有的地方,并考虑将服务扩展到其他设施。应利用远程保健加快咨询和治疗。适当时应使用低分割,以减轻旅行负担。治疗医生应了解交通服务和现场住宿或住院的选择,并向患者提供,以减轻与旅行有关的障碍。
{"title":"Consensus Statement Supporting the Presence of Onsite Radiation Oncology Departments at VHA Medical Centers.","authors":"Ruchika Gutt,&nbsp;Ronald H Shapiro,&nbsp;Steve P Lee,&nbsp;Katherine Faricy-Anderson,&nbsp;Lori Hoffman-Hogg,&nbsp;Abhishek A Solanki,&nbsp;Edwinette Moses,&nbsp;George A Dawson,&nbsp;Maria D Kelly","doi":"10.12788/fp.0308","DOIUrl":"https://doi.org/10.12788/fp.0308","url":null,"abstract":"<p><strong>Background: </strong>Although multiple studies demonstrate that radiotherapy is underused worldwide, the impact that onsite radiation oncology at medical centers has on the use of radiotherapy is poorly studied. The Veterans Health Administration (VHA) Palliative Radiotherapy Taskforce has evaluated the impact of onsite radiation therapy on the use of palliative radiation and has made recommendations based on these findings.</p><p><strong>Observations: </strong>Radiation consults and treatment occur in a more timely manner at VHA centers with onsite radiation therapy compared with VHA centers without onsite radiation oncology. Referring practitioners with onsite radiation oncology less frequently report difficulty contacting a radiation oncologist (0% vs 20%, respectively; <i>P</i> = .006) and patient travel (28% vs 71%, respectively; <i>P</i> < .001) as barriers to referral for palliative radiotherapy. Facilities with onsite radiation oncology are more likely to have multidisciplinary tumor boards (31% vs 3%, respectively; <i>P</i> = .11) and are more likely to be influenced by radiation oncology recommendations at tumor boards (69% vs 44%, respectively; <i>P</i> = .02).</p><p><strong>Conclusions: </strong>The VHA Palliative Radiotherapy Taskforce recommends the optimization of the use of radiotherapy within the VHA. Radiation oncology services should be maintained where present in the VHA, with consideration for expansion of services to additional facilities. Telehealth should be used to expedite consults and treatment. Hypofractionation should be used, when appropriate, to ease travel burden. Options for transportation services and onsite housing or hospitalization should be understood by treating physicians and offered to patients to mitigate barriers related to travel.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"S8-S11"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662312/pdf/fp-39-08s-s08.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender and Patient Satisfaction in a Veterans Health Administration Outpatient Chemotherapy Unit. 退伍军人卫生管理局门诊化疗单位的性别与患者满意度。
Pub Date : 2022-08-01 Epub Date: 2022-08-24 DOI: 10.12788/fp.0292
Malinda T West, Gagah P Tamba, Rajat Thawani, Antonene Drew, Nicole V Wilde, Julie N Graff, Rosemarie Mannino

Background: Our objective was to explore whether differences in patient satisfaction based on gender exist at the Veterans Affairs Portland Health Care System (VAPHCS) outpatient chemotherapy infusion unit.

Methods: Veterans who received outpatient infusion treatments at the VAPHCS outpatient chemotherapy infusion unit from 2018 to 2020 were invited to take an anonymous survey. Response differences were analyzed using Fisher exact and Welch t tests. Male and female patient lists were first generated based on Computerized Patient Record System designation, then defined and results reported based on gender self-identification from survey responses.

Results: The survey was conducted over a 2-week period during January and February of 2021. In total, 69 veterans were contacted: 21 (70%) of 30 female and 20 (51%) of 39 male veterans completed the survey. Most (62%) female patients were aged < 65 years, and 52% were treated for breast cancer. Most (90%) male patients were aged ≥ 65 years, and most commonly treated for prostate cancer (20%) or a hematologic malignancy (20%). Using our survey, patient satisfaction (SD) was 8.7 (2.2) on a 10-point scale among women, and 9.6 (0.6) among men (P = .11). History of sexual abuse or harassment was reported by 86% of women compared with 10% of men (P < .001). Women reported feeling uncomfortable around other patients in the infusion unit compared with men (29% vs 0%; P = .02) and discomfort in relaying uncomfortable feelings to a clinician (29% vs 0%; P = .02).

Conclusions: Gender seems to be related to how veterans with cancer perceive their ambulatory cancer care. This may be due to the combination of a high history of sexual abuse and/or harassment among women who represent a minority of the total infusion unit population, the majority of whom receive treatment for a primarily gender-specific breast malignancy. Analysis was limited by the small sample size of women, many with advanced malignancy.

背景:我们的目的是探讨退伍军人事务部波特兰卫生保健系统(VAPHCS)门诊化疗输液单元患者满意度是否存在性别差异。方法:对2018 - 2020年在VAPHCS门诊化疗输液单元接受门诊输液治疗的退伍军人进行匿名调查。采用Fisher精确检验和Welch t检验分析反应差异。男性和女性患者名单首先根据计算机患者记录系统的指定生成,然后根据调查回应的性别自我认同来定义和报告结果。结果:该调查于2021年1月至2月进行,为期两周。总共联系了69名退伍军人:30名女性退伍军人中有21名(70%)完成了调查,39名男性退伍军人中有20名(51%)完成了调查。大多数(62%)女性患者年龄< 65岁,52%接受乳腺癌治疗。大多数(90%)男性患者年龄≥65岁,最常见的治疗是前列腺癌(20%)或血液恶性肿瘤(20%)。根据我们的调查,女性患者满意度(SD)为8.7(2.2)(10分制),男性患者满意度(SD)为9.6 (0.6)(P = 0.11)。86%的女性报告有性虐待或性骚扰史,而10%的男性报告有性骚扰史(P < 0.001)。与男性相比,女性报告在输液单元与其他患者在一起时感到不舒服(29%对0%;P = .02)和向临床医生传达不舒服感觉的不适(29% vs 0%;P = .02)。结论:性别似乎与癌症退伍军人如何看待他们的门诊癌症护理有关。这可能是由于在整个输液单位人口中占少数的妇女中有很高的性虐待和/或骚扰史,其中大多数人接受的主要是性别特异性乳腺恶性肿瘤的治疗。分析受到女性样本量小的限制,许多女性患有晚期恶性肿瘤。
{"title":"Gender and Patient Satisfaction in a Veterans Health Administration Outpatient Chemotherapy Unit.","authors":"Malinda T West,&nbsp;Gagah P Tamba,&nbsp;Rajat Thawani,&nbsp;Antonene Drew,&nbsp;Nicole V Wilde,&nbsp;Julie N Graff,&nbsp;Rosemarie Mannino","doi":"10.12788/fp.0292","DOIUrl":"https://doi.org/10.12788/fp.0292","url":null,"abstract":"<p><strong>Background: </strong>Our objective was to explore whether differences in patient satisfaction based on gender exist at the Veterans Affairs Portland Health Care System (VAPHCS) outpatient chemotherapy infusion unit.</p><p><strong>Methods: </strong>Veterans who received outpatient infusion treatments at the VAPHCS outpatient chemotherapy infusion unit from 2018 to 2020 were invited to take an anonymous survey. Response differences were analyzed using Fisher exact and Welch <i>t</i> tests. Male and female patient lists were first generated based on Computerized Patient Record System designation, then defined and results reported based on gender self-identification from survey responses.</p><p><strong>Results: </strong>The survey was conducted over a 2-week period during January and February of 2021. In total, 69 veterans were contacted: 21 (70%) of 30 female and 20 (51%) of 39 male veterans completed the survey. Most (62%) female patients were aged < 65 years, and 52% were treated for breast cancer. Most (90%) male patients were aged ≥ 65 years, and most commonly treated for prostate cancer (20%) or a hematologic malignancy (20%). Using our survey, patient satisfaction (SD) was 8.7 (2.2) on a 10-point scale among women, and 9.6 (0.6) among men (<i>P</i> = .11). History of sexual abuse or harassment was reported by 86% of women compared with 10% of men (<i>P</i> < .001). Women reported feeling uncomfortable around other patients in the infusion unit compared with men (29% vs 0%; <i>P</i> = .02) and discomfort in relaying uncomfortable feelings to a clinician (29% vs 0%; <i>P</i> = .02).</p><p><strong>Conclusions: </strong>Gender seems to be related to how veterans with cancer perceive their ambulatory cancer care. This may be due to the combination of a high history of sexual abuse and/or harassment among women who represent a minority of the total infusion unit population, the majority of whom receive treatment for a primarily gender-specific breast malignancy. Analysis was limited by the small sample size of women, many with advanced malignancy.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"e0292"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662310/pdf/fp-39-08s-e0292.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Treatment of Nonmelanoma Skin Cancer in Older Adult Veterans. 老年退伍军人非黑色素瘤皮肤癌的外科治疗。
Pub Date : 2022-08-01 Epub Date: 2022-07-15 DOI: 10.12788/fp.0283
Loretta Coady-Fariborzian, Christy Anstead, Ssg Anna Paul

Background: Older adult patients are frequently referred to surgical services for the treatment of nonmelanoma skin cancer (NMSC). The appropriateness of offering surgery to patients with serious comorbidities and a limited life expectancy has been questioned in the literature. The purpose of this study was to determine the morbidity and 5-year mortality for patients with NMSC referred to the plastic surgery service.

Methods: A retrospective chart review was performed from July 1, 2011, to June 30, 2015, of all plastic surgery service consults for the treatment of NMSC. We collected the following data: age and life-limiting comorbidities at the time of referral, treatment, complications, and 5-year mortality. A χ2 analysis was used to determine the statistical significance (P < .05) between the individual risk factors and 5-year mortality. The relative risk of 5-year mortality was calculated combining advanced age with individual comorbidities.

Results: The plastic surgery service completed 800 consults for NMSC over a 4-year period. Five-year mortality was 28.6%. Median age of patients deceased at 5 years was 78 years at the time of the consult submission. The surgical complication rate was 5%. Aged ≥ 80 years, coronary artery disease, congestive heart failure, cerebral vascular disease, peripheral vascular disease, dementia, chronic kidney disease, chronic obstructive pulmonary disease, and diabetes mellitus were found individually to be statistically significant predictors of 5-year mortality. Combining aged ≥ 80 years, coronary artery disease, congestive heart failure, or dementia increased the 5-year mortality to a relative risk > 3.

Conclusions: Surgical excision of NMSC in older adult patients is indicated in most situations. A frank discussion with the patient and caregiver is suggested. Surgical treatment of NMSC in older adult patients has a low morbidity but needs to be balanced against a patient's quality of life when they present with life-limiting comorbidities.

背景:老年患者经常被转诊到外科治疗非黑色素瘤皮肤癌(NMSC)。文献中对向有严重并发症且预期寿命有限的患者提供手术治疗是否合适提出了质疑。本研究旨在确定转诊至整形外科的 NMSC 患者的发病率和 5 年死亡率:方法:我们对 2011 年 7 月 1 日至 2015 年 6 月 30 日期间所有整形外科治疗 NMSC 的病例进行了回顾性病历审查。我们收集了以下数据:转诊时的年龄和限制性并发症、治疗、并发症和 5 年死亡率。我们采用χ2分析来确定各个风险因素与5年死亡率之间的统计学意义(P < .05)。结合高龄和个别并发症计算出了5年死亡率的相对风险:整形外科在4年内完成了800例NMSC会诊。5年死亡率为28.6%。5年后死亡患者的中位年龄为就诊时的78岁。手术并发症发生率为 5%。研究发现,年龄≥80 岁、冠状动脉疾病、充血性心力衰竭、脑血管疾病、外周血管疾病、痴呆症、慢性肾脏疾病、慢性阻塞性肺疾病和糖尿病是单独预测 5 年死亡率的重要因素。结合年龄≥80岁、冠状动脉疾病、充血性心力衰竭或痴呆症等因素,5年死亡率的相对风险大于3:结论:在大多数情况下,对老年患者进行 NMSC 手术切除是适宜的。建议与患者和护理人员进行坦诚讨论。对老年 NMSC 患者进行手术治疗的发病率较低,但当患者出现危及生命的合并症时,需要权衡患者的生活质量。
{"title":"Surgical Treatment of Nonmelanoma Skin Cancer in Older Adult Veterans.","authors":"Loretta Coady-Fariborzian, Christy Anstead, Ssg Anna Paul","doi":"10.12788/fp.0283","DOIUrl":"10.12788/fp.0283","url":null,"abstract":"<p><strong>Background: </strong>Older adult patients are frequently referred to surgical services for the treatment of nonmelanoma skin cancer (NMSC). The appropriateness of offering surgery to patients with serious comorbidities and a limited life expectancy has been questioned in the literature. The purpose of this study was to determine the morbidity and 5-year mortality for patients with NMSC referred to the plastic surgery service.</p><p><strong>Methods: </strong>A retrospective chart review was performed from July 1, 2011, to June 30, 2015, of all plastic surgery service consults for the treatment of NMSC. We collected the following data: age and life-limiting comorbidities at the time of referral, treatment, complications, and 5-year mortality. A χ<sup>2</sup> analysis was used to determine the statistical significance (<i>P</i> < .05) between the individual risk factors and 5-year mortality. The relative risk of 5-year mortality was calculated combining advanced age with individual comorbidities.</p><p><strong>Results: </strong>The plastic surgery service completed 800 consults for NMSC over a 4-year period. Five-year mortality was 28.6%. Median age of patients deceased at 5 years was 78 years at the time of the consult submission. The surgical complication rate was 5%. Aged ≥ 80 years, coronary artery disease, congestive heart failure, cerebral vascular disease, peripheral vascular disease, dementia, chronic kidney disease, chronic obstructive pulmonary disease, and diabetes mellitus were found individually to be statistically significant predictors of 5-year mortality. Combining aged ≥ 80 years, coronary artery disease, congestive heart failure, or dementia increased the 5-year mortality to a relative risk > 3.</p><p><strong>Conclusions: </strong>Surgical excision of NMSC in older adult patients is indicated in most situations. A frank discussion with the patient and caregiver is suggested. Surgical treatment of NMSC in older adult patients has a low morbidity but needs to be balanced against a patient's quality of life when they present with life-limiting comorbidities.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":" ","pages":"S45-S49"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662309/pdf/fp-39-08s-s45.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacist-Assisted Varenicline Tobacco Cessation Treatment for Veterans. 退伍军人的药剂师辅助伐尼克兰戒烟治疗。
Pub Date : 2022-07-01 Epub Date: 2022-07-15 DOI: 10.12788/fp.0290
Ariane R Guthrie, Mahendra A Patel, Catherine J Sweet

Background: Pharmacists are uniquely positioned to provide tobacco cessation interventions given their medication expertise and accessibility to the public. The purpose of this study was to evaluate the efficacy and safety of management of varenicline by clinical pharmacy specialists (CPSs) compared with other clinicians.

Methods: This retrospective chart review included patients with a varenicline prescription between July 1, 2019, and July 31, 2020. Primary outcomes were reduction in tobacco use at 12 weeks from baseline, continuous abstinence at 12 weeks, adherence to varenicline therapy, and time to first follow-up. For safety evaluation, charts were reviewed for documented adverse drug reactions.

Results: Management by CPS compared with other clinicians was associated with similar mean (SD) reductions of tobacco use (-7.9 [10.4] vs -5.4 [9.8] cigarettes per day, respectively; P = .15) and rates of complete abstinence (34% vs 38%, respectively; P = .73) and higher adherence (42% vs 31%, respectively; P = .01). Mean (SD) time to first follow-up was shorter for patients in the CPS group: 52 (66) vs 163 (110) days; P < .001. Adverse events were more common in the CPS group compared with the other clinicians group (42% vs 23%; P = .02).

Conclusions: These results suggest that CPS management of varenicline is as safe and effective as management by other clinicians. Additional research is needed to fully characterize the impact of pharmacist management of varenicline, justify expansion of CPS scope of practice, and ultimately enhance patient outcomes regarding tobacco cessation.

背景:药剂师在提供戒烟干预方面具有独特的地位,因为他们的药物专业知识和公众的可及性。本研究的目的是评价临床药学专家(cps)与其他临床医生对伐尼克兰管理的有效性和安全性。方法:本回顾性研究纳入2019年7月1日至2020年7月31日期间服用伐尼克兰处方的患者。主要结局是在12周时从基线开始减少烟草使用,12周时持续戒烟,坚持伐尼克兰治疗,以及第一次随访的时间。为了安全性评估,我们回顾了药物不良反应的记录。结果:与其他临床医生相比,CPS管理与烟草使用减少的平均(SD)相似(分别为-7.9[10.4]和-5.4[9.8]支/天);P = 0.15)和完全戒断率(分别为34% vs 38%;P = 0.73)和更高的依从性(分别为42% vs 31%;P = 0.01)。CPS组患者到首次随访的平均(SD)时间更短:52(66)天和163(110)天;P < 0.001。与其他临床医生组相比,CPS组的不良事件更常见(42% vs 23%;P = .02)。结论:这些结果表明,瓦伦尼克兰的CPS管理与其他临床医生的管理一样安全有效。需要进一步的研究来充分描述varenicline药师管理的影响,证明CPS实践范围的扩大,并最终提高患者戒烟的结果。
{"title":"Pharmacist-Assisted Varenicline Tobacco Cessation Treatment for Veterans.","authors":"Ariane R Guthrie,&nbsp;Mahendra A Patel,&nbsp;Catherine J Sweet","doi":"10.12788/fp.0290","DOIUrl":"https://doi.org/10.12788/fp.0290","url":null,"abstract":"<p><strong>Background: </strong>Pharmacists are uniquely positioned to provide tobacco cessation interventions given their medication expertise and accessibility to the public. The purpose of this study was to evaluate the efficacy and safety of management of varenicline by clinical pharmacy specialists (CPSs) compared with other clinicians.</p><p><strong>Methods: </strong>This retrospective chart review included patients with a varenicline prescription between July 1, 2019, and July 31, 2020. Primary outcomes were reduction in tobacco use at 12 weeks from baseline, continuous abstinence at 12 weeks, adherence to varenicline therapy, and time to first follow-up. For safety evaluation, charts were reviewed for documented adverse drug reactions.</p><p><strong>Results: </strong>Management by CPS compared with other clinicians was associated with similar mean (SD) reductions of tobacco use (-7.9 [10.4] vs -5.4 [9.8] cigarettes per day, respectively; <i>P</i> = .15) and rates of complete abstinence (34% vs 38%, respectively; <i>P</i> = .73) and higher adherence (42% vs 31%, respectively; <i>P</i> = .01). Mean (SD) time to first follow-up was shorter for patients in the CPS group: 52 (66) vs 163 (110) days; <i>P</i> < .001. Adverse events were more common in the CPS group compared with the other clinicians group (42% vs 23%; <i>P</i> = .02).</p><p><strong>Conclusions: </strong>These results suggest that CPS management of varenicline is as safe and effective as management by other clinicians. Additional research is needed to fully characterize the impact of pharmacist management of varenicline, justify expansion of CPS scope of practice, and ultimately enhance patient outcomes regarding tobacco cessation.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"39 7","pages":"304-309"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648582/pdf/fp-39-07-304.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40704950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriateness of Pharmacologic Thromboprophylaxis Prescribing Based on Padua Score Among Inpatient Veterans. 基于帕多瓦评分的住院退伍军人血栓预防药物处方的适宜性。
Pub Date : 2022-07-01 Epub Date: 2022-07-14 DOI: 10.12788/fp.0291
Bianca Creith, Gabrielle Givens, Bishoy Ragheb, Nilam Naik, Casey Owen, Jessica Wallace

Background: Hospitalized patients are at increased risk of developing venous thromboembolism (VTE). The Padua Prediction Score (PPS) was developed to help quantify the risk of VTE for hospitalized patients and guide prescribing of pharmacologic thromboprophylaxis. This study aims to assess whether PPS embedded within an admission order set was utilized appropriately to prescribe or withhold pharmacologic thromboprophylaxis.

Methods: This single center, retrospective observational cohort study evaluated adult patients aged ≥ 18 years between June 2017 and June 2020. A random sample of 250 patient charts meeting inclusion criteria were reviewed to calculate PPSs, and clinician notes were reviewed for documentation as to whether thromboprophylaxis was given or withheld appropriately based on the PPS. A second cohort of patients admitted within the study period meeting inclusion criteria and readmitted for VTE within 45 days of discharge were evaluated to determine appropriateness of inpatient VTE thromboprophylaxis during index hospitalization based on the PPS.

Results: Of the 250 patients examined, 118 (47.2%) had a PPS < 4 on admission. Of the 118 patients, 58 (49.2%) were inappropriately prescribed pharmacologic thromboprophylaxis administered within 24 hours of admission. The clinical rationale for giving thromboprophylaxis when not indicated was provided for only 2 (3.4%) of the 58 patients. Of the 132 patients with a PPS ≥ 4, 11 (8.3%) had thromboprophylaxis appropriately withheld and for 33 (25.0%) it was inappropriately withheld. A total of 88 (66.7%) patients received thromboprophylaxis as indicated by a PPS ≥ 4.

Conclusions: Despite the inclusion of the PPS calculator in the facility's admission order set, this study showed pharmacologic thromboprophylaxis was frequently inappropriately given or withheld. This suggests written protocols and order sets may not be solely sufficient to ensure appropriate VTE prophylaxis in actual practice. Incorporation of additional tools, such as dashboards and scorecards, should be explored.

背景:住院患者发生静脉血栓栓塞(VTE)的风险增加。开发帕多瓦预测评分(PPS)是为了帮助量化住院患者静脉血栓栓塞的风险,并指导药物血栓预防处方。本研究的目的是评估是否PPS嵌入入院令集被适当地用于开或保留药理学血栓预防。方法:这项单中心、回顾性观察队列研究评估了2017年6月至2020年6月期间年龄≥18岁的成年患者。随机抽取250例符合纳入标准的患者图表进行评估,以计算PPS,并审查临床医生的记录,以确定是否根据PPS适当给予或不给予血栓预防。第二组患者在研究期间入院,符合纳入标准,出院后45天内因静脉血栓栓塞再次入院,评估以PPS为基础的指数住院期间静脉血栓栓塞预防的适宜性。结果:250例患者中,118例(47.2%)入院时PPS < 4。在118名患者中,58名(49.2%)患者在入院24小时内不适当地给予了药物血栓预防。58例患者中只有2例(3.4%)提供了在无指征时给予血栓预防的临床理由。在132例PPS≥4的患者中,11例(8.3%)有适当的血栓预防,33例(25.0%)有不适当的血栓预防。共有88例(66.7%)患者接受了PPS≥4的血栓预防治疗。结论:尽管在医院的入院单中包含了PPS计算器,但这项研究显示药理学血栓预防经常被不恰当地给予或拒绝。这表明书面协议和指令集可能不足以确保在实际操作中适当的静脉血栓栓塞预防。应该探索合并其他工具,如仪表板和记分卡。
{"title":"Appropriateness of Pharmacologic Thromboprophylaxis Prescribing Based on Padua Score Among Inpatient Veterans.","authors":"Bianca Creith,&nbsp;Gabrielle Givens,&nbsp;Bishoy Ragheb,&nbsp;Nilam Naik,&nbsp;Casey Owen,&nbsp;Jessica Wallace","doi":"10.12788/fp.0291","DOIUrl":"https://doi.org/10.12788/fp.0291","url":null,"abstract":"<p><strong>Background: </strong>Hospitalized patients are at increased risk of developing venous thromboembolism (VTE). The Padua Prediction Score (PPS) was developed to help quantify the risk of VTE for hospitalized patients and guide prescribing of pharmacologic thromboprophylaxis. This study aims to assess whether PPS embedded within an admission order set was utilized appropriately to prescribe or withhold pharmacologic thromboprophylaxis.</p><p><strong>Methods: </strong>This single center, retrospective observational cohort study evaluated adult patients aged ≥ 18 years between June 2017 and June 2020. A random sample of 250 patient charts meeting inclusion criteria were reviewed to calculate PPSs, and clinician notes were reviewed for documentation as to whether thromboprophylaxis was given or withheld appropriately based on the PPS. A second cohort of patients admitted within the study period meeting inclusion criteria and readmitted for VTE within 45 days of discharge were evaluated to determine appropriateness of inpatient VTE thromboprophylaxis during index hospitalization based on the PPS.</p><p><strong>Results: </strong>Of the 250 patients examined, 118 (47.2%) had a PPS < 4 on admission. Of the 118 patients, 58 (49.2%) were inappropriately prescribed pharmacologic thromboprophylaxis administered within 24 hours of admission. The clinical rationale for giving thromboprophylaxis when not indicated was provided for only 2 (3.4%) of the 58 patients. Of the 132 patients with a PPS ≥ 4, 11 (8.3%) had thromboprophylaxis appropriately withheld and for 33 (25.0%) it was inappropriately withheld. A total of 88 (66.7%) patients received thromboprophylaxis as indicated by a PPS ≥ 4.</p><p><strong>Conclusions: </strong>Despite the inclusion of the PPS calculator in the facility's admission order set, this study showed pharmacologic thromboprophylaxis was frequently inappropriately given or withheld. This suggests written protocols and order sets may not be solely sufficient to ensure appropriate VTE prophylaxis in actual practice. Incorporation of additional tools, such as dashboards and scorecards, should be explored.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"39 7","pages":"299-303a"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648584/pdf/fp-39-07-299.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40704951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Learning Health System Approach to Long COVID Care. 学习卫生系统方法实现COVID - 19长期护理。
Pub Date : 2022-07-01 Epub Date: 2022-07-11 DOI: 10.12788/fp.0288
Allison M Gustavson, Amanda Purnell, Marian Adly, Omar Awan, Norbert Bräu, Nicholas A Braus, Mon S Bryant, Lynn Chang, Cherina Cyborski, Babak Darvish, Larissa B Del Piero, Tammy L Eaton, Amelia Kiliveros, Heather Kloth, Eric R McNiel, Megan A Miller, Alana Patrick, Patrick Powers, Morgan Pyne, Idelka G Rodriguez, Jennifer Romesser, Brittany Rud, Ilana Seidel, Alexandria Tepper, Hanh Trinh, Brionn Tonkin, Johnson Vachachira, Hlee Yang, Joshua R Shak

Background: Global initiatives to mitigate COVID-19 transmission have shifted health system priorities to management of patients with prolonged long COVID symptoms. To better meet the needs of patients, clinicians, and systems, a learning health system approach can use rapid-cycle methods to integrate data and real-world experience to iteratively evaluate and adapt models of long COVID care.

Observations: Employees in the Veterans Health Administration formed a multidisciplinary workgroup. We sought to develop processes to learn more about this novel long COVID syndrome and innovative long COVID care models that can be applied within and outside of our health care system. We describe our workgroup processes and goals to create a mechanism for cross-facility communication, identify gaps in care and research, and cocreate knowledge on best practices for long COVID care delivery.

Conclusions: The learning health system approach will be critical in reimagining health care service delivery after the COVID-19 pandemic.

背景:缓解COVID-19传播的全球行动已将卫生系统的重点转移到管理长期出现COVID-19症状的患者。为了更好地满足患者、临床医生和系统的需求,学习型卫生系统方法可以使用快速循环方法整合数据和实际经验,以迭代评估和调整COVID - 19长期护理模型。观察:退伍军人健康管理局的雇员组成了一个多学科工作组。我们试图制定流程,以更多地了解这种新型长COVID综合征和创新的长COVID护理模式,这些模式可以在我们的医疗系统内外应用。我们描述了我们的工作组流程和目标,以创建跨机构沟通机制,确定护理和研究方面的差距,并共同创造关于长期COVID护理提供最佳实践的知识。结论:在COVID-19大流行之后,学习型卫生系统方法对于重塑卫生保健服务提供至关重要。
{"title":"A Learning Health System Approach to Long COVID Care.","authors":"Allison M Gustavson,&nbsp;Amanda Purnell,&nbsp;Marian Adly,&nbsp;Omar Awan,&nbsp;Norbert Bräu,&nbsp;Nicholas A Braus,&nbsp;Mon S Bryant,&nbsp;Lynn Chang,&nbsp;Cherina Cyborski,&nbsp;Babak Darvish,&nbsp;Larissa B Del Piero,&nbsp;Tammy L Eaton,&nbsp;Amelia Kiliveros,&nbsp;Heather Kloth,&nbsp;Eric R McNiel,&nbsp;Megan A Miller,&nbsp;Alana Patrick,&nbsp;Patrick Powers,&nbsp;Morgan Pyne,&nbsp;Idelka G Rodriguez,&nbsp;Jennifer Romesser,&nbsp;Brittany Rud,&nbsp;Ilana Seidel,&nbsp;Alexandria Tepper,&nbsp;Hanh Trinh,&nbsp;Brionn Tonkin,&nbsp;Johnson Vachachira,&nbsp;Hlee Yang,&nbsp;Joshua R Shak","doi":"10.12788/fp.0288","DOIUrl":"https://doi.org/10.12788/fp.0288","url":null,"abstract":"<p><strong>Background: </strong>Global initiatives to mitigate COVID-19 transmission have shifted health system priorities to management of patients with prolonged long COVID symptoms. To better meet the needs of patients, clinicians, and systems, a learning health system approach can use rapid-cycle methods to integrate data and real-world experience to iteratively evaluate and adapt models of long COVID care.</p><p><strong>Observations: </strong>Employees in the Veterans Health Administration formed a multidisciplinary workgroup. We sought to develop processes to learn more about this novel long COVID syndrome and innovative long COVID care models that can be applied within and outside of our health care system. We describe our workgroup processes and goals to create a mechanism for cross-facility communication, identify gaps in care and research, and cocreate knowledge on best practices for long COVID care delivery.</p><p><strong>Conclusions: </strong>The learning health system approach will be critical in reimagining health care service delivery after the COVID-19 pandemic.</p>","PeriodicalId":73021,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"39 7","pages":"310-314"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648579/pdf/fp-39-07-310.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40704945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Federal practitioner : for the health care professionals of the VA, DoD, and PHS
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1